Nanotechnology Stocks To Watch Today – February 09th

OSI Systems, NVE, and Clene are the three Nanotechnology stocks to watch today, according to MarketBeat’s stock screener tool. Nanotechnology stocks refer to investments in companies that are engaged in the research, development, and commercialization of products or services related to nanotechnology. These stocks are often associated with innovative technologies at the nano-scale, offering potential for growth and advancement in various industries such as healthcare, electronics, energy, and materials science. Investors in nanotechnology stocks may seek opportunities to capitalize on the potential impact of nanotechnology on future markets and industries. These companies had the highest dollar trading volume of any Nanotechnology stocks within the last several days.

OSI Systems (OSIS)

OSI Systems, Inc. designs and manufactures electronic systems and components. It operates in three segments: Security, Healthcare, and Optoelectronics and Manufacturing. The Security segment offers baggage and parcel inspection, cargo and vehicle inspection, hold baggage and people screening, radiation monitoring, explosive and narcotics trace detection systems, and optical inspection systems under the Rapiscan name.

OSI Systems stock traded up $1.03 during trading hours on Friday, reaching $207.07. The stock had a trading volume of 279,627 shares, compared to its average volume of 230,907. OSI Systems has a 52 week low of $126.57 and a 52 week high of $209.40. The company has a market cap of $3.48 billion, a price-to-earnings ratio of 26.65, a PEG ratio of 1.74 and a beta of 1.19. The company has a debt-to-equity ratio of 0.56, a current ratio of 1.88 and a quick ratio of 1.25. The business’s 50 day moving average price is $178.57 and its 200-day moving average price is $157.78.

NVE (NVEC)

NVE Corporation develops and sells devices that use spintronics, a nanotechnology that relies on electron spin to acquire, store, and transmit information in the United States and internationally. The company manufactures spintronic products, including sensors and couplers for use in acquiring and transmitting data.

NASDAQ:NVEC traded down $1.15 during midday trading on Friday, reaching $70.65. 28,427 shares of the stock traded hands, compared to its average volume of 28,095. The business has a 50-day moving average of $78.00 and a two-hundred day moving average of $78.82. The stock has a market capitalization of $341.95 million, a PE ratio of 22.79 and a beta of 1.11. NVE has a 12-month low of $67.35 and a 12-month high of $90.24.

Clene (CLNN)

Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug candidate is CNM-Au8, which is being studied in various clinical trials, including a completed Phase 2 platform trial to evaluate the safety and efficacy of CNM-Au8 in patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; completed two open-label investigator blinded Phase 2 clinical trials on the brain's energy metabolites; completed Phase 2 clinical trial for the treatment of visual pathway deficits in chronic optic neuropathy for remyelination in stable relapsing Multiple Sclerosis; and a second Phase 2 clinical trial for the treatment of patients with Parkinson's Diseases.

NASDAQ:CLNN traded down $0.06 during mid-day trading on Friday, hitting $4.36. 54,823 shares of the company’s stock traded hands, compared to its average volume of 47,025. The company has a fifty day moving average of $4.79 and a 200 day moving average of $5.05. Clene has a twelve month low of $3.82 and a twelve month high of $10.65.